Hyalusol Equality is an aerosol consisting of 10 vials of 8 ml each, designed to offer an effective hydrating and soothing solution for the care of the mucous membranes, in particular the ocular and nasal ones. The advanced formulation guarantees a deep hydrating action, essential for alleviating dryness and discomfort caused by multiple environmental and pathological factors.
The aerosol is simple to use thanks to the single-dose vials, which ensure maximum hygiene and convenience during application. Each dispensing is delicate and well-dosed, designed to effectively reach the mucous membranes to be treated without causing discomfort or irritation.
Hyalusol Equality is ideal for those who need a daily treatment that supports the natural humidification of the mucous membranes, preventing the appearance of irritation and maintaining a feeling of freshness and well-being. Suitable for different age groups and conditions, this product easily integrates into personal care routines, both in home and clinical settings.
Therapeutic Indications
Hyalusol Equality aerosol is indicated for the treatment and prevention of dryness and irritation of the ocular and nasal mucous membranes. It is particularly useful in conditions such as dry conjunctivitis, irritations due to environmental factors such as wind, dust, heating and air conditioning, as well as in subjects who use electronic devices for long periods, whose prolonged use can contribute to the onset of dry eye syndrome.
In the medical field, it can also be used as a support for the therapy of temporary or chronic inflammatory conditions of the mucous membranes, helping to maintain a moist environment conducive to healing. Furthermore, it is suitable for people who need additional hydration of the mucous membranes in case of seasonal allergies or mechanical stress such as frequent use of contact lenses.
The product works by forming a protective film that helps maintain natural hydration, thus reducing itching, burning and foreign body sensation, significantly improving the quality of daily life. Its action is therefore preventive and therapeutic, allowing wide application in multiple clinical and environmental situations.
Composition
The formulation of Hyalusol Equality aerosol is characterized by the inclusion of hydrating and soothing active ingredients, designed to guarantee effectiveness and safety. Among the main components are hyaluronic acid in a highly purified form, known for its ability to retain water up to 1000 times its own weight, contributing to the protection and regeneration of the mucous membranes. This particular substance promotes the creation of a humectant film that keeps the mucous membranes hydrated for longer, effectively counteracting dehydration.
Other excipients present ensure the stability and compatibility of the solution with the mucous tissues, respecting the natural physiological properties and minimizing the risk of irritation or allergies. The composition is free of aggressive preservatives, making the product also suitable for frequent and prolonged use over time. Each single-dose vial contains a calibrated quantity of active ingredient, ensuring precise and safe administration, without dispersions or waste.
The attention in the choice of ingredients and their purity make Hyalusol Equality aerosol a high quality solution, effective in every application and safe for all users, including subjects with particular sensitivities or allergies to more invasive chemical components. The formulation meets the highest standards of safety and tolerability, offering a delicate but powerfully hydrating treatment.
Contraindications
Hyalusol Equality aerosol does not present significant contraindications for the majority of users, however, use is not recommended in the presence of known or proven hypersensitivity to the components of the formula, such as hyaluronic acid or other excipients present. It is important to avoid direct application in case of serious ocular or nasal infections in progress, as the product does not have specific antimicrobial properties and may not be indicated as the sole treatment.
If irritation, persistent redness or adverse reactions appear during use, it is advisable to discontinue
